QI
CORT icon

QS Investors’s Corcept Therapeutics CORT Stock Holding History

QS Investors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,104
Closed -$542K – 1205
2020
Q3 		$542K Sell
31,104
-131,308
-81% -$2.09M 0.01% 652
2020
Q2 		$2.73M Hold
162,412
– – 0.04% 373
2020
Q1 		$1.93M Sell
162,412
-5,161
-3% -$63.9K 0.03% 425
2019
Q4 		$2.02M Sell
167,573
-2,951
-2% -$41.1K 0.02% 581
2019
Q3 		$2.41M Hold
170,524
– – 0.03% 501
2019
Q2 		$1.9M Sell
170,524
-2,946
-2% -$32.8K 0.02% 602
2019
Q1 		$2.04M Sell
173,470
-1,010
-0.6% -$12.6K 0.02% 603
2018
Q4 		$2.33M Hold
174,480
– – 0.03% 490
2018
Q3 		$2.45M Sell
174,480
-1,013
-0.6% -$14.2K 0.02% 559
2018
Q2 		$2.76M Buy
175,493
+15
+0% +$261 0.03% 493
2018
Q1 		$2.89M Sell
175,478
-12,231
-7% -$227K 0.03% 444
2017
Q4 		$3.39M Sell
187,709
-6,783
-3% -$123K 0.03% 433
2017
Q3 		$3.75M Buy
194,492
+193,479
+19,100% +$2.88M 0.03% 398
2017
Q2 		$12K Hold
1,013
– – ﹤0.01% 1589
2017
Q1 		$11K Hold
1,013
– – ﹤0.01% 1630
2016
Q4 		$7K Hold
1,013
– – ﹤0.01% 1444
2016
Q3 		$7K Hold
1,013
– – ﹤0.01% 1440
2016
Q2 		$6K Hold
1,013
– – ﹤0.01% 1463
2016
Q1 		$5K Hold
1,013
– – ﹤0.01% 1469
2015
Q4 		$5K Hold
1,013
– – ﹤0.01% 1468
2015
Q3 		$4K Buy
+1,013
New +$5.14K ﹤0.01% 1426

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

QS Investors's CORT Position: Q4 2020 in Review

QS Investors sold out of Corcept Therapeutics (CORT) in Q4 2020, closing a stake of 31,104 shares — an estimated $542K sold.

QS Investors first reported a position in CORT in Q3 2015 and held it in 21 quarters. The position peaked at $3.75M in Q3 2017. 226 funds tracked by Wall St. Rank hold CORT as of Q4 2020.

  • QS Investors reported no remaining Corcept Therapeutics position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 31,104 Corcept Therapeutics shares in Q4 2020, an estimated $542K.
  • QS Investors first reported a position in Corcept Therapeutics in Q3 2015 and held it in 21 quarters.
  • QS Investors's Corcept Therapeutics position peaked at $3.75M in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.